Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

RetinalGenix Technologies Q3 2026 Results: Net Loss of $433K, Loss Narrows

RetinalGenix Technologies Inc. reported a net loss of $1,330,911 for the nine months ended September 30, 2026, with zero revenue as it remains in the development stage. The company faces significant liquidity challenges with only $5 in cash and an accumulated deficit of $19.2 million, leading to substantial doubt about its ability to continue as a going concern.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-0.4-0.6
EPS (diluted, $ a share)$-0.02$-0.03

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: RTGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

RetinalGenix Technologies Inc.: key numbers

Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.